The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma
Abstract
Basal cell carcinoma (BCC) of the skin is the most common malignant neoplasm in humans. BCC is primarily driven by the Sonic Hedgehog (Hh) pathway. However, its phenotypic variation remains unexplained. Our genetic profiling of 293 BCCs found the highest mutation rate in cancer (65 mutations/Mb). Eighty-five percent of the BCCs harbored mutations in Hh pathway genes (PTCH1, 73% or SMO, 20% (P = 6.6 × 10−8) and SUFU, 8%) and in TP53 (61%). However, 85% of the BCCs also harbored additional driver mutations in other cancer-related genes. We observed recurrent mutations in MYCN (30%), PPP6C (15%), STK19 (10%), LATS1 (8%), ERBB2 (4%), PIK3CA (2%), and NRAS, KRAS or HRAS (2%), and loss-of-function and deleterious missense mutations were present in PTPN14 (23%), RB1 (8%) and FBXW7 (5%). Consistent with the mutational profiles, N-Myc and Hippo-YAP pathway target genes were upregulated. Functional analysis of the mutations in MYCN, PTPN14 and LATS1 suggested their potential relevance in BCC tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn923 · Cited by 14,108
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Integrative analysis of 111 reference human epigenomes
Roadmap Epigenomics Consortium, Kundaje, A., Meuleman, W., Ernst, J., Bilenky, M., Yen, A., Heravi-Moussavi, A., Kheradpour, P., Zhang, Z., Wang, J., et al. (2015) · Nature · doi:10.1038/nature14248 · Cited by 6,368
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
Cibulskis, K., Lawrence, M. S., Carter, S. L., Sivachenko, A., Jaffe, D., Sougnez, C., Gabriel, S., Meyerson, M., Lander, E. S., & Getz, G. (2013) · Nature Biotechnology · doi:10.1038/nbt.2514 · Cited by 4,981
Comprehensive genomic characterization of head and neck squamous cell carcinomas
The Cancer Genome Atlas Network (2015) · Nature · doi:10.1038/nature14129 · Cited by 3,877
Mermel, C. H., Schumacher, S. E., Hill, B., Meyerson, M. L., Beroukhim, R., & Getz, G. (2011) · Genome Biology · doi:10.1186/gb-2011-12-4-r41 · Cited by 3,550
Genomic classification of cutaneous melanoma
Akbani, R., Akdemir, K. C., Aksoy, B. A., Albert, M., Ally, A., Amin, S. B., Arachchi, H., Arora, A., Auman, J. T., Ayala, B., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.044 · Cited by 3,151
Discovery and saturation analysis of cancer genes across 21 tumour types
Lawrence, M. S., Stojanov, P., Mermel, C. H., Robinson, J. T., Garraway, L. A., Golub, T. R., Meyerson, M., Gabriel, S. B., Lander, E. S., & Getz, G. (2014) · Nature · doi:10.1038/nature12912 · Cited by 3,096
Comparative Protein Structure Modeling Using MODELLER
Eswar, N., Webb, B., Marti‐Renom, M. A., Madhusudhan, M. S., Eramian, D., Shen, M., Pieper, U., & Sali, A. (2007) · Current Protocols in Protein Science · doi:10.1002/0471140864.ps0209s50 · Cited by 2,846
A landscape of driver mutations in melanoma
Hodis, E., Watson, I. R., Kryukov, G. V., Arold, S. T., Imielinski, M., Theurillat, J.-P., Nickerson, E., Auclair, D., Li, L., Place, C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.024 · Cited by 2,610
Prediction of central nervous system embryonal tumour outcome based on gene expression
Pomeroy, S. L., Tamayo, P., Gaasenbeek, M., Sturla, L. M., Angelo, M., McLaughlin, M. E., Kim, J. Y. H., Goumnerova, L. C., Black, P. M., Lau, C., et al. (2002) · Nature · doi:10.1038/415436a · Cited by 2,371
Mutations of the Human Homolog of Drosophila patched in the Nevoid Basal Cell Carcinoma Syndrome
Hahn, H., Wicking, C., Zaphiropoulos, P. G., Gailani, M. R., Shanley, S., Chidambaram, A., Vorechovsky, I., Holmberg, E., Unden, A. B., Gillies, S., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81268-4 · Cited by 2,022
Guerois, R., Nielsen, J. E., & Serrano, L. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00442-4 · Cited by 1,728
Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
Sekulic, A., Migden, M. R., Oro, A. E., Dirix, L., Lewis, K. D., Hainsworth, J. D., Solomon, J. A., Yoo, S., Arron, S. T., Friedlander, P. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113713 · Cited by 1,464
Scalable web services for the PSIPRED Protein Analysis Workbench
Buchan, D. W. A., Minneci, F., Nugent, T. C. O., Bryson, K., & Jones, D. T. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt381 · Cited by 1,318
Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma
Krauthammer, M., Kong, Y., Ha, B. H., Evans, P., Bacchiocchi, A., McCusker, J. P., Cheng, E., Davis, M. J., Goh, G., Choi, M., et al. (2012) · Nature Genetics · doi:10.1038/ng.2359 · Cited by 1,191
The genetic landscape of high-risk neuroblastoma
Pugh, T. J., Morozova, O., Attiyeh, E. F., Asgharzadeh, S., Wei, J. S., Auclair, D., Carter, S. L., Cibulskis, K., Hanna, M., Kiezun, A., et al. (2013) · Nature Genetics · doi:10.1038/ng.2529 · Cited by 1,186
Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma
Von Hoff, D. D., LoRusso, P. M., Rudin, C. M., Reddy, J. C., Yauch, R. L., Tibes, R., Weiss, G. J., Borad, M. J., Hann, C. L., Brahmer, J. R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905360 · Cited by 1,109
Self-citationWelcker, M., & Clurman, B. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2290 · Cited by 1,084
Yap1 acts downstream of α-catenin to control epidermal proliferation
Schlegelmilch, K., Mohseni, M., Kirak, O., Pruszak, J., Rodriguez, J. R., Zhou, D., Kreger, B. T., Vasioukhin, V., Avruch, J., Brummelkamp, T. R., et al. (2011) · Cell · doi:10.1016/j.cell.2011.02.031 · Cited by 1,036
Welcker, M., Orian, A., Jin, J., Grim, J. A., Harper, J. W., Eisenman, R. N., & Clurman, B. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402770101 · Cited by 941
Genomic Analysis of Non- NF2 Meningiomas Reveals Mutations in TRAF7 , KLF4 , AKT1 , and SMO
Clark, V. E., Erson-Omay, E. Z., Serin, A., Yin, J., Cotney, J., Özduman, K., Avşar, T., Li, J., Murray, P. B., Henegariu, O., et al. (2013) · Science · doi:10.1126/science.1233009 · Cited by 912
Tumor Suppressor LATS1 Is a Negative Regulator of Oncogene YAP
Hao, Y., Chun, A., Cheung, K., Rashidi, B., & Yang, X. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709037200 · Cited by 786
Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations
Brastianos, P. K., Horowitz, P. M., Santagata, S., Jones, R. T., McKenna, A., Getz, G., Ligon, K. L., Palescandolo, E., Van Hummelen, P., Ducar, M. D., et al. (2013) · Nature Genetics · doi:10.1038/ng.2526 · Cited by 651
Zhang, H., Liu, C.-Y., Zha, Z.-Y., Zhao, B., Yao, J., Zhao, S., Xiong, Y., Lei, Q.-Y., & Guan, K.-L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900843200 · Cited by 569
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups
Ellison, D. W., Dalton, J., Kocak, M., Nicholson, S. L., Fraga, C., Neale, G., Kenney, A. M., Brat, D. J., Perry, A., Yong, W. H., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0800-8 · Cited by 563
Couzens, A. L., Knight, J. D. R., Kean, M. J., Teo, G., Weiss, A., Dunham, W. H., Lin, Z.-Y., Bagshaw, R. D., Sicheri, F., Pawson, T., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004712 · Cited by 441
Hedgehog regulates cell growth and proliferation by inducing Cyclin D and Cyclin E
Duman-Scheel, M., Weng, L., Xin, S., & Du, W. (2002) · Nature · doi:10.1038/417299a · Cited by 434
Zhang, H., Pasolli, H. A., & Fuchs, E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019603108 · Cited by 419
Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma
Nikolaev, S. I., Rimoldi, D., Iseli, C., Valsesia, A., Robyr, D., Gehrig, C., Harshman, K., Guipponi, M., Bukach, O., Zoete, V., et al. (2012) · Nature Genetics · doi:10.1038/ng.1026 · Cited by 409
Self-citationSmoothened Variants Explain the Majority of Drug Resistance in Basal Cell Carcinoma
Atwood, S. X., Sarin, K. Y., Whitson, R. J., Li, J. R., Kim, G., Rezaee, M., Ally, M. S., Kim, J., Yao, C., Chang, A. L. S., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.02.002 · Cited by 404
Brash, D. E. (2015) · Photochemistry and Photobiology · doi:10.1111/php.12377 · Cited by 401
Identification of the cell lineage at the origin of basal cell carcinoma
Youssef, K. K., Van Keymeulen, A., Lapouge, G., Beck, B., Michaux, C., Achouri, Y., Sotiropoulou, P. A., & Blanpain, C. (2010) · Nature Cell Biology · doi:10.1038/ncb2031 · Cited by 401
Somatic mutations in the PTCH,SMOH,SUFUH and TP53 genes in sporadic basal cell carcinomas
Reifenberger, J., Wolter, M., Knobbe, C. B., Köhler, B., Schönicke, A., Scharwächter, C., Kumar, K., Blaschke, B., Ruzicka, T., & Reifenberger, G. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06353.x · Cited by 399
Genomic Analysis of Smoothened Inhibitor Resistance in Basal Cell Carcinoma
Sharpe, H. J., Pau, G., Dijkgraaf, G. J., Basset-Seguin, N., Modrusan, Z., Januario, T., Tsui, V., Durham, A. B., Dlugosz, A. A., Haverty, P. M., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.02.001 · Cited by 382
Self-citationThe mutational landscape of cutaneous T cell lymphoma and Sézary syndrome
da Silva Almeida, A. C., Abate, F., Khiabanian, H., Martinez-Escala, E., Guitart, J., Tensen, C. P., Vermeer, M. H., Rabadan, R., Ferrando, A., & Palomero, T. (2015) · Nature Genetics · doi:10.1038/ng.3442 · Cited by 379
Identification of recurrent SMO and BRAF mutations in ameloblastomas
Sweeney, R. T., McClary, A. C., Myers, B. R., Biscocho, J., Neahring, L., Kwei, K. A., Qu, K., Gong, X., Ng, T., Jones, C. D., et al. (2014) · Nature Genetics · doi:10.1038/ng.2986 · Cited by 366
The Ubiquitin Ligase FBXW7 Modulates Leukemia-Initiating Cell Activity by Regulating MYC Stability
King, B., Trimarchi, T., Reavie, L., Xu, L., Mullenders, J., Ntziachristos, P., Aranda-Orgilles, B., Perez-Garcia, A., Shi, J., Vakoc, C., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.041 · Cited by 347
Self-citationWong, Y.-H., Lee, T.-Y., Liang, H.-K., Huang, C.-M., Wang, T.-Y., Yang, Y.-H., Chu, C.-H., Huang, H.-D., Ko, M.-T., & Hwang, J.-K. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm322 · Cited by 343
Gerdes, J., Becker, M. H. G., Key, G., Cattoretti, G., Sanders, H. W., Smith, A. G., Crocker, J., Darnton, S. J., Gray, M. R., & Crocker, J. (1992) · The Journal of Pathology · doi:10.1002/path.1711680114 · Cited by 320
Smith, M. J., Beetz, C., Williams, S. G., Bhaskar, S. S., O’Sullivan, J., Anderson, B., Daly, S. B., Urquhart, J. E., Bholah, Z., Oudit, D., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.2569 · Cited by 300
The eukaryotic linear motif resource ELM: 10 years and counting
Dinkel, H., Van Roey, K., Michael, S., Davey, N. E., Weatheritt, R. J., Born, D., Speck, T., Krüger, D., Grebnev, G., Kubań, M., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1047 · Cited by 293
Pfister, S., Remke, M., Benner, A., Mendrzyk, F., Toedt, G., Felsberg, J., Wittmann, A., Devens, F., Gerber, N. U., Joos, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.9432 · Cited by 293
Bahram, F., von der Lehr, N., Cetinkaya, C., & Larsson, L.-G. (2000) · Blood · doi:10.1182/blood.v95.6.2104 · Cited by 286
Mutant p53: an oncogenic transcription factor
Strano, S., Dell'Orso, S., Di Agostino, S., Fontemaggi, G., Sacchi, A., & Blandino, G. (2007) · Oncogene · doi:10.1038/sj.onc.1210296 · Cited by 269
Hu, J., Adar, S., Selby, C. P., Lieb, J. D., & Sancar, A. (2015) · Genes & Development · doi:10.1101/gad.261271.115 · Cited by 255
Basset-Seguin, N., Hauschild, A., Grob, J.-J., Kunstfeld, R., Dréno, B., Mortier, L., Ascierto, P. A., Licitra, L., Dutriaux, C., Thomas, L., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)70198-1 · Cited by 244
Self-citationedgeR for Differential RNA-seq and ChIP-seq Analysis: An Application to Stem Cell Biology
Nikolayeva, O., & Robinson, M. D. (2014) · Methods in Molecular Biology · doi:10.1007/978-1-4939-0512-6_3 · Cited by 228
Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification
Valentijn, L. J., Koster, J., Haneveld, F., Aissa, R. A., van Sluis, P., Broekmans, M. E. C., Molenaar, J. J., van Nes, J., & Versteeg, R. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208215109 · Cited by 228
Mutational Landscape of Basal Cell Carcinomas by Whole-Exome Sequencing
Jayaraman, S. S., Rayhan, D. J., Hazany, S., & Kolodney, M. S. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.276 · Cited by 221
Impact of replication timing on non-CpG and CpG substitution rates in mammalian genomes
Chen, C.-L., Rappailles, A., Duquenne, L., Huvet, M., Guilbaud, G., Farinelli, L., Audit, B., d'Aubenton-Carafa, Y., Arneodo, A., Hyrien, O., et al. (2010) · Genome Research · doi:10.1101/gr.098947.109 · Cited by 212
PTPN14 is required for the density-dependent control of YAP1
Wang, W., Huang, J., Wang, X., Yuan, J., Li, X., Feng, L., Park, J.-I., & Chen, J. (2012) · Genes & Development · doi:10.1101/gad.192955.112 · Cited by 195
Initial Assessment of Tumor Regrowth After Vismodegib in Advanced Basal Cell Carcinoma
Chang, A. L. S., & Oro, A. E. (2012) · Archives of Dermatology · doi:10.1001/archdermatol.2012.2354 · Cited by 176
Function of the c‐Myc oncoprotein
Kato, G. J., & Dang, C. V. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.12.1521738 · Cited by 164
Recurrent point mutations in the kinetochore gene KNSTRN in cutaneous squamous cell carcinoma
Lee, C. S., Bhaduri, A., Mah, A., Johnson, W. L., Ungewickell, A., Aros, C. J., Nguyen, C. B., Rios, E. J., Siprashvili, Z., Straight, A., et al. (2014) · Nature Genetics · doi:10.1038/ng.3091 · Cited by 143
Chromosome 6p amplification and cancer progression
Santos, G. C., Zieleńska, M., Prasad, M., & Squire, J. A. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.034389 · Cited by 111
Besaratinia, A., Kim, S.-I., Bates, S. E., & Pfeifer, G. P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610534104 · Cited by 107
Multiple mechanisms of MYCN dysregulation in Wilms tumour
Williams, R. D., Chagtai, T., Alcaide-German, M., Apps, J. R., Wegert, J., Popov, S., Vujanic, G. M., van Tinteren, H., van den Heuvel‐Eibrink, M. M., Kool, M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3377 · Cited by 106
MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastoma
Lodrini, M., Oehme, I., Schroeder, C., Milde, T., Schier, M. C., Kopp‐Schneider, A., Schulte, J. H., Fischer, M., Preter, K. D., Pattyn, F., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt346 · Cited by 98
Repair and Transcription: Collision or collusion?
Hanawalt, P. C., Donahue, B. A., & Sweder, K. S. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00112-3 · Cited by 98
Wilson, K. E., Li, Y.-W., Yang, N., Shen, H., Orillion, A. R., & Zhang, J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.534701 · Cited by 92
Extrachromosomal driver mutations in glioblastoma and low-grade glioma
Nikolaev, S. I., Santoni, F. A., Garieri, M., Makrythanasis, P., Falconnet, E., Guipponi, M., Vannier, A., Radovanovic, I., Béna, F., Forestier, F., et al. (2014) · Nature Communications · doi:10.1038/ncomms6690 · Cited by 89
Self-citationMcGregor, J. M., Crook, T., Fraser-Andrews, E. A., Rozycka, M., Crossland, S., Brooks, L. A., & Whittaker, S. J. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00507.x · Cited by 87
Mutual interaction between YAP and c-Myc is critical for carcinogenesis in liver cancer
Xiao, W., Wang, J., Ou, C., Zhang, Y., Ma, L., Weng, W., Pan, Q., & Sun, F. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.08.071 · Cited by 85
Neural Precursor Cycling at Sonic Speed: N-Myc Pedals, GSK-3 Brakes
Knoepfler, P. S., & Kenney, A. M. (2005) · Cell Cycle · doi:10.4161/cc.5.1.2292 · Cited by 81
Hammond, D. E., Zeng, K., Espert, A., Bastos, R. N., Baron, R. D., Grüneberg, U., & Barr, F. A. (2013) · Journal of Cell Science · doi:10.1242/jcs.128397 · Cited by 81
Iwasaki, J. K., Srivastava, D., Moy, R. L., Lin, H. J., & Kouba, D. J. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.06.054 · Cited by 75
New basal cell carcinoma susceptibility loci
Stacey, S., Helgason, H., Gudjonsson, S. A., Þorleifsson, G., Zink, F., Sigurðsson, Á., Kehr, B., Guðmundsson, J., Sulem, P., Sigurgeirsson, B., et al. (2015) · Nature Communications · doi:10.1038/ncomms7825 · Cited by 73
Frequent cases of RAS-mutated Down syndrome acute lymphoblastic leukaemia lack JAK2 mutations
Nikolaev, S. I., Garieri, M., Santoni, F. A., Falconnet, E., Ribaux, P., Guipponi, M., Murray, A., Groet, J., Giarin, E., Basso, G., et al. (2014) · Nature Communications · doi:10.1038/ncomms5654 · Cited by 64
Self-citationProtein Phosphatase PP6 N Terminal Domain Restricts G1to S Phase Progression in Human Cancer Cells
Stefansson, B., & Brautigan, D. L. (2007) · Cell Cycle · doi:10.4161/cc.6.11.4276 · Cited by 57
MEK1 promotes YAP and their interaction is critical for tumorigenesis in liver cancer
Li, L., Wang, J., Zhang, Y., Zhang, Y., Ma, L., Weng, W., Qiao, Y., Xiao, W., Wang, H., Yu, W., et al. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.10.042 · Cited by 44
Sonic Hedgehog pathway is essential for neuroblastoma cell proliferation and tumor growth
Xu, L., Wang, X., Wan, J., Li, T., Gong, X., Zhang, K., Liang, Y., Xiang, Z., Xu, M., & Cui, H. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1222-6 · Cited by 37
Clinical Benefit Assessment of Vismodegib Therapy in Patients With Advanced Basal Cell Carcinoma
Dréno, B., Basset‐Séguin, N., Caro, I., et al. (2014) · The Oncologist · doi:10.1634/theoncologist.2014-0003 · Cited by 36
Marionnet, C., Benoit, A., Benhamou, S., Sarasin, A., & Stary, A. (1995) · Journal of Molecular Biology · doi:10.1006/jmbi.1995.0519 · Cited by 31 · cited 1×
“5 cm between the tumors) that were T3 (24) Ear T2 (25) Ear VS037 T7 (24) Leg T6 (9) Leg”
BackgroundMurphy, A. J., Pierce, J. M., de Caestecker, C. R., Libes, J. M., Neblett, D., deCaestecker, M. P., Perantoni, A. O., Tanigawa, S., Anderson, J. R., Dome, J. S., et al. (2013) · Pediatric Blood & Cancer · doi:10.1002/pbc.24788 · Cited by 26
Mutations in the Kinetochore Gene KNSTRN in Basal Cell Carcinoma
Jaju, P. D., Nguyen, C. B., Mah, A., Atwood, S. X., Li, J., Zia, A., Chang, A. L. S., Oro, A. E., Tang, J. Y., Lee, C. S., et al. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.339 · Cited by 21
Drobetsky, E. A., & Sage, E. (1993) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/0027-5107(93)90062-k · Cited by 21
Recurrent NMYC copy number gain and high protein expression in basal cell carcinoma
Freier, K., Flechtenmacher, C., Devens, F., Hartschuh, W., Hofele, C., Lichter, P., & Joos, S. (2006) · Oncology Reports · doi:10.3892/or.15.5.1141 · Cited by 21
Tate, G., Kishimoto, K., & Mitsuya, T. (2014) · Medical Molecular Morphology · doi:10.1007/s00795-014-0086-8 · Cited by 7
Cited by
Clonal replacement of tumor-specific T cells following PD-1 blockade
Yost, K. E., Satpathy, A. T., Wells, D. K., Qi, Y., Wang, C., Kageyama, R., McNamara, K. L., Granja, J. M., Sarin, K. Y., Brown, R. A., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0522-3 · Cited by 1,534
The Hippo Signaling Pathway in Development and Disease
Zheng, Y., & Pan, D. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.06.003 · Cited by 867
Cameron, M. C., Lee, E., Hibler, B. P., Barker, C. A., Mori, S., Cordova, M., Nehal, K. S., & Rossi, A. M. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.03.060 · Cited by 525
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer
Wang, Y., Xu, X., Maglic, D., Dill, M. T., Mojumdar, K., Ng, P. K.-S., Jeong, K. J., Tsang, Y. H., Moreno, D., Bhavana, V. H., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.10.001 · Cited by 500
MYC Deregulation in Primary Human Cancers
Kalkat, M., De Melo, J., Hickman, K., Lourenco, C., Redel, C., Resetca, D., Tamachi, A., Tu, W., & Penn, L. (2017) · Genes · doi:10.3390/genes8060151 · Cited by 443
Metadata
- Authors
- Bonilla, X., Parmentier, L., King, B., Bezrukov, F., Kaya, G., Zoete, V., Seplyarskiy, V. B., Sharpe, H. J., McKee, T., Letourneau, A., Ribaux, P. G., Popadin, K., Basset-Seguin, N., Chaabene, R. B., Santoni, F. A., Andrianova, M. A., Guipponi, M., Garieri, M., Verdan, C., Grosdemange, K., Sumara, O., Eilers, M., Aifantis, I., Michielin, O., de Sauvage, F. J., Antonarakis, S. E., & Nikolaev, S. I.
- Venue
- Nature Genetics
- Published
- 2016-03-07
- Volume
- 48
- Issue
- 4
- Pages
- 398-406
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2293178613
- Cited by
- 490
- References
- 85
- FWCI
- 38.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.